Prague Scientific provides a vast array of services to support our partners in delivering complex modalities in a simplified way to the patients.
We specialize in harnessing the power of small molecules and oligonucleotides with API, various drug product technologies and capacities to offer best solutions tailored to the exact needs of our clients.
Our commercial strategy is focused on six technology platforms, each with its own target profile attribute:

• Small molecules;
• oligo-nucleotides;
• oral solids;
• oral liquids;
• injectables;
• topical and ophthalmic.

Within each platform, Prague Scientific partners with our clients individually to tailor the client’s scope and appropriate technology application, facilitate the development and scale-up of the product, establish pricing and budget alongside the sales team and oversees the alignment with operations and project management teams to deliver a customized execution plan for the project journey. All technology platforms are supported by our global network of fully-integrated cGMP facilities and seasoned project management teams to secure our client‘s supply chain across the development and manufacturing of drug substance and the products services spanning all phases of the drug life-cycle.